MTF2 and retinoblastoma: Using both gain- and loss-of-function perturbations in two retinoblastoma cell lines, they demonstrated that MTF2 is a target of the lncRNA colon cancer-associated transcript 1 (CCAT1)/miR-218-5p regulatory axis.